Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBU
2726
DELISTED
Brookfield Business Partners
BBU
| $1M | ﹤0.01% |
32,700
-96,147
| -75% | -$2.73M |
|
|
RAPT
2727
DELISTED
RAPT Therapeutics
RAPT
| $1M | ﹤0.01% |
5,688
+3,325
| +141% | +$628K |
|
2728
Concrete Pumping Holdings
BBCP
$484M
| $1M | ﹤0.01% |
149,267
-121,880
| -45% | -$936K |
|
2729
nLIGHT
LASR
$3.03B
| $999K | ﹤0.01% |
57,600
+35,600
| +162% | +$670K |
|
2730
Lands' End
LE
$384M
| $996K | ﹤0.01% |
58,883
+27,400
| +87% | +$490K |
|
|
ETNB
2731
DELISTED
89bio
ETNB
| $993K | ﹤0.01% |
+263,400
| New | +$1.7M |
|
2732
Equity Residential
EQR
$24.7B
| $989K | ﹤0.01% |
11,000
-185,100
| -94% | -$16.3M |
|
2733
Texas Roadhouse
TXRH
$13.6B
| $988K | ﹤0.01% |
11,800
-86,572
| -88% | -$7.41M |
|
2734
Kaltura
KLTR
$249M
| $987K | ﹤0.01% |
551,300
+122,700
| +29% | +$337K |
|
2735
Vaxcyte
PCVX
$8.64B
| $985K | ﹤0.01% |
40,800
+27,800
| +214% | +$607K |
|
2736
Innoviz Technologies
INVZ
$107M
| $981K | ﹤0.01% |
271,000
+105,200
| +63% | +$420K |
|
2737
iShares International Treasury Bond ETF
IGOV
$1.53B
| $980K | ﹤0.01% |
21,100
+14,000
| +197% | +$676K |
|
|
UBFO
2738
DELISTED
United Security Bancshares
UBFO
| $975K | ﹤0.01% |
117,448
-13,727
| -10% | -$114K |
|
|
SYRS
2739
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $975K | ﹤0.01% |
+81,896
| New | +$1.46M |
|
|
CFB
2740
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $974K | ﹤0.01% |
61,800
+16,900
| +38% | +$268K |
|
|
AIOT
2741
PowerFleet Inc
AIOT
$417M
| $973K | ﹤0.01% |
327,449
-37,100
| -10% | -$136K |
|
2742
Koppers
KOP
$891M
| $969K | ﹤0.01% |
+35,200
| New | +$1.04M |
|
|
FRGI
2743
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $968K | ﹤0.01% |
129,500
-3,300
| -2% | -$31.6K |
|
2744
Citizens
CIA
$201M
| $967K | ﹤0.01% |
227,994
+5,300
| +2% | +$24K |
|
2745
Ohio Valley Banc Corp
OVBC
$210M
| $966K | ﹤0.01% |
32,075
-1,300
| -4% | -$39.4K |
|
2746
Byline Bancorp
BY
$1.78B
| $965K | ﹤0.01% |
36,171
+5,000
| +16% | +$136K |
|
2747
MGE Energy Inc
MGEE
$3.09B
| $965K | ﹤0.01% |
12,100
+100
| +0.8% | +$7.6K |
|
2748
ADMA Biologics
ADMA
$2.12B
| $964K | ﹤0.01% |
526,700
+177,800
| +51% | +$277K |
|
2749
Insperity
NSP
$1.99B
| $964K | ﹤0.01% |
+9,600
| New | +$957K |
|
|
XNET
2750
Xunlei
XNET
$334M
| $964K | ﹤0.01% |
547,807
-269,656
| -33% | -$465K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.